Idolazzi, L <br/><br/>
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study.  [electronic resource] 

 -  Bone  Oct 2017 
 - 144-149 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1873-2763 
<br/><br/><label>Standard No.: </label>10.1016/j.bone.2017.07.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Bone Density--drug effects<br/>Bone Density Conservation Agents--therapeutic use<br/>Bone and Bones--drug effects<br/>Child<br/>Diphosphonates--therapeutic use<br/>Female<br/>Humans<br/>Italy<br/>Male<br/>Osteogenesis Imperfecta--drug therapy